Guobang Pharma (SHSE:605507) Construction In Progress: ¥398 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:605507 Guobang Pharma Ltd SHSE:605507
88 GF Score
Price ¥16.30
GF Value ¥16.00
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Guobang Pharma Construction In Progress?

Guobang Pharma SHSE:605507 +0.06% 88 Construction In Progress is ¥398 Mil as of Mar. 2026. GuruFocus rates SHSE:605507 with a GF Score™ of 88/100 and a GF Value™ of ¥16.00 (Fairly Valued). The stock has 4 warning signs investors should review.

Guobang Pharma's quarterly construction in progress declined from Sep. 2025 (¥312 Mil) to Dec. 2025 (¥283 Mil) but then increased from Dec. 2025 (¥283 Mil) to Mar. 2026 (¥398 Mil).

Guobang Pharma's annual construction in progress declined from Dec. 2023 (¥637 Mil) to Dec. 2024 (¥255 Mil) but then increased from Dec. 2024 (¥255 Mil) to Dec. 2025 (¥283 Mil).

Guobang Pharma Construction In Progress Historical Data

* Premium members only.

The historical data trend for Guobang Pharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guobang Pharma Construction In Progress Chart

Guobang Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 827.47 874.85 636.65 255.26 282.88

Guobang Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 295.91 276.36 311.58 282.88 398.50
SHSE:605507
88GF Score
Guobang Pharma Ltd SHSE:605507
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guobang Pharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥398 Mil mean?
Guobang Pharma (SHSE:605507) has a Construction In Progress of ¥398 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Guobang Pharma and its competitors.
Is Guobang Pharma's Construction In Progress too high?
Guobang Pharma's current Construction In Progress is ¥398 Mil. Overall, Guobang Pharma has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guobang Pharma's Construction In Progress compare to ZTS?
Guobang Pharma's Construction In Progress of ¥398 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Guobang Pharma and its competitors. Guobang Pharma's current Construction In Progress is ¥398 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guobang Pharma stock overvalued right now?
Based on GuruFocus' analysis, Guobang Pharma (SHSE:605507) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.00, compared to a current price of ¥16.30 — trading 1.9% above its estimated fair value. The current Construction In Progress is ¥398 Mil. Guobang Pharma's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Guobang Pharma (SHSE:605507), the current Construction In Progress is ¥398 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guobang Pharma (SHSE:605507) Overvalued in 2026?

Based on GuruFocus' analysis, Guobang Pharma stock appears to be overvalued. The current stock price of ¥16.30 is trading 1.9% above its estimated GF Value™ of ¥16.00. GuruFocus considers Guobang Pharma to be Fairly Valued.

Key valuation signals for SHSE:605507:

  • Construction In Progress: ¥398 Mil
  • GF Value™: ¥16.00 vs. price of ¥16.30 (1.9% above fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the SHSE:605507 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guobang Pharma Business Description

Address No. 60, Xingmei Avenue, Provincial High-tech Industrial Park, Zhejiang Province, Xinchang, CHN, 312500
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.
88GF Score

Get the complete analysis for SHSE:605507

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.30
Price
¥16.00
GF Value